Mianserin Viatris (Mianserin Hydrochloride)

Mianserin works by blocking central presynaptic α2‑adrenergic receptors and several serotonin receptors (5‑HT2, 5‑HT3). This antagonism increases the release of norepinephrine and serotonin, which are key neurotransmitters involved in mood regulation.

The appropriate dose of Mianserin is individualized and set by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are typically made gradually to balance efficacy and side‑effects.

The safety of Mianserin during pregnancy and lactation has not been definitively established. Healthcare providers usually weigh potential benefits against unknown risks and may consider alternative treatments for pregnant or nursing individuals.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mianserin belongs to the tetracyclic class, differing from selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) in its receptor profile. It often causes less sexual dysfunction than SSRIs but may be more sedating, making it suitable for patients with insomnia‑related depressive symptoms.

Store Mianserin tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Mianserin is taken orally, usually once daily in the evening to reduce daytime sedation. Tablets should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe hypotension, cardiac arrhythmias such as QT prolongation, and rare cases of hepatotoxicity. Patients should report any signs of infection, fainting, palpitations, or jaundice to their physician promptly.

Mianserin is contraindicated in individuals with known hypersensitivity to the drug, those currently taking monoamine oxidase inhibitors, or patients with severe hepatic impairment. Caution is also advised for patients with a history of cardiac conduction disorders or blood dyscrasias.